ARNA Blockchain Biotech Ecosystem

token.arnagenomics.com

rating review

Token Lab Index: 63% (neutral)

web — tokenlab.info facebook — facebook.com/tokenlab.info twitter — twitter.com/tokenlab_info telegram — t.me/tokenlab_info

September, 20 2017

� TokenLab.info �1

Table of ContentsARNA 1 Token Lab Index: 1 63% (neutral) 1Table of Contents 2ARNA 3

Summary 3Scoring model 4Is there a problem? 7Pros 8Cons 8Team 9For information 10Legal compliance 10Additional info 11Investment strategy 12

� TokenLab.info �2

ARNA Summary

ARNA is a complex project, which includes 2 major ideas:

1. Development of evidentiary medicine in early diagnosis of oncological diseases. ARNA Genomics team has invented and patented ARNA BC (breast cancer) test, which is able to diagnose breast cancer at early stages with very high accuracy.

2. Development of ARNA Panacea blockchain platform, which main purpose - creation of distributed storage and marketplace for biotech inventions, research and development, clinical trials stage and further marketing of products, thus creating a full-cycle ecosystem.

ARNA Panacea ecosystem is a platform which not only provide functionality for distributed and protected storage of medical data, but will server as well as a marketplace for all biotech market participants, who are involved in processes of new biotech technologies development and further proof.

Therefore, such marketplace stores, processes and uses medical data with segregated levels of access depending on user role. Also this allows to motivate scientists and researchers to bring to the market new products, while final consumers (patients) are able to purchase them after clinical trials and required approvals.

� TokenLab.info �3

Scoring model How to read scoring model:- Each value is measured using 5-point scale- Each value has weight coefficient (from 1 to 3), showing its importance (the higher — the more

important is the criterion)- Weighted value is a multiple of 2 shown above values- At the bottom of the spreadsheet there are average value using 5-point scale and weighted-

avenge value (for friendly usage score shows at per cents)

Weight Value Score

Weighted score

Project

Title Arna

Website token.arnagenomics.com

WhitePaper 3 token.arnagenomics.com/ARNA_whitepaper_en.html

5 15

Age of domain 2 21.04.2015 5 10

Date of ICO 2 19.11.2017 - 03.12.2017 4 8

Prototype / MVP

iOS 2 No 1 2

Android 2 No 1 2

Web 2 No 1 2

Desktop 2 Yes (Test ARNA BC) 5 10

Team

Successful project before

3 Yes 4 15

Advisors 3 Yes, both tech and business 5 15Key team members

3 Egor Melnikov, George Nikitin 5 15

External fundingInvestments before ICO?

2 Yes, seed (Skolkovo - no sum, and Angels) 4 8

Platform Ethereum

First mention of the project

2 2013 5 10

Community / Participants

Own blog (e.g. Medium)

1 https://medium.com/@arnagenomics

2 2

GitHub 2 No 1 2

� TokenLab.info �4

Facebook 1 facebook.com/arnagenomics 2 2

Reddit 1 No

Twitter - twits / followers

1 twitter.com/ArnaGenomics 2 2

Telegram 1t.me/arnagenomics t.me/arnagenomics_ru t.me/arnagenomics_channel

2 2

Slack 1 No 1 1

Cap min 2 $1mln 5 10

max 2 $40mln 3 6

Media

Bitcointalk 1

BitcoinTalk [ANN] https://bitcointalk.org/index.php?topic=2181117

BitcoinTalk [Bounty] https://bitcointalk.org/index.php?topic=2181165

3 3

Coindesk 1 No

Other 1

Press-relises and publish:http://www.newsbtc.com/2017/09/15/arna-blockchain-cancer-research-solution/http://www.the-blockchain.com/2017/09/14/arna-genomics-introduces-revolutionary-solution-cancer-diagnostics-treatment-biotechnologies-blockchain-ecosystem-arna-panacea/ https://bitcoinexchangeguide.com/arna-genomics/https://forklog.com/blokchejn-ekosistema-arna-panacea-obedinit-rynok-meditsinskih-issledovanij/

3 3

� TokenLab.info �5

Legal status compared to SEC report

ARNA genomics emits Utility Tokens, which are not securities

Name of token ARNA token

Ticker ARNA

Purchase mechanism

ETH

Type of token ERC-20Additional markers

CommentsUnsold tokens policy: transferred into marketing budget

Emission of tokens

1 000 000 000

Score: 63% (neutral)

� TokenLab.info �6

Is there a problem? Yes, the problem exists. A huge problem exists in two ways, which are targeted by the project.

Problem of tests, which allow to detect cancer tumour on early stages. Currently projected price is $100 per 1 test, required to either build own network of laboratories/centers, or partner with existing medical centres network.

There is also a problem of unavailability of medical data, problem of market launch and financing of some activities during research, development and proving of biotech product.

Platform is developed to solve both problems, brining to the market DNA breast cancer test ARNA BC as a first in line product, and developing a sophisticated system of researcher motivation for the future projects.

� TokenLab.info �7

Pros 1. Existing, scientifically proved, patented DNA breast cancer test ARNA BC;2. Unique expertise and breakthrough project technology;; 3. Huge potential market (patients) = over 1.1 bil Women p.y., and this Number is slowly

increasing from year to year;; 4. Vast opportunities and ways of test application. Plans to launch not only ARNA BC test, bit

also other test (colon cancer, lung, etc.); 5. Availability of platform ARNA Panacea for various market participants, each one of which

has own goals and ways of use of the platform; 6. Social focus of the project and major product.

Cons 1. Possible obstacles from large market players for which such changes will create huge

losses including lowering of the clinical trials costs, etc.; 2. Technical risks of such large-scale project realisation and attraction of users-consumers; 3. Legal barriers (country-specific, not always applicable).

� TokenLab.info �8

Team The project team is very strong from healthcare point of view as well as from management expertise. Team members have unique expertise and competencies required for correct and fast development of the project. Advisors of ARNA Genomics are making these positions even stronger on local and global market, making project much more competitive.

� TokenLab.info �9

For information ARNA Genomics company has received Russian patent on ARNA BC and filed applications internationally. Company has rich experience in healthcare research, including oncological diseases (started in 2013).

Currently the company has technological advantage — the working product with low cost of sales and outstanding medical characteristics. “Technology” of this product and unique “know-hows” create a large basis for the company in relation to the competitors.

Besides, the company has support from Russian medical universities and biotech cluster of Skolkovo fund.

Legal compliance Company and its leaders will comply with required regulating procedures in selected jurisdictions in order to work legally and openly. To acquire tokens residents of US and China need to pass KYC procedure (https://token.arnagenomics.com/waitlist/).

� TokenLab.info �10

Additional info This project is especially interesting while it is not only pursuing profits, but also has strong social responsibility goals.Also project has important points, that allow to identify it as attractive for investment, which are:

• Experienced team• Strong advisors covering all project aspects• Existing product• Licenses and patents protecting unique products• Well described and detailed long-term strategy

� TokenLab.info �11

Investment strategy 1. Buy tokens on pre-sale, getting maximum discount. 2. Hold tokens until ICO is over (in case of speculative strategy) or hold a long position (in case of

long-term investment).3. Used tokens at own concern

It is planned that token price will grow with growth of ARNA BC test users (patients) and users of ARNA Panacea system, where tokens will be required for getting access to unique biotech R&D products.

Company also plans in case it is in compliance with regulators requirements to conduct private placement at discounted price of non-control stake of SPV company granted with exclusive license for test and rights for ARNA Panacea system amongst holders of large amount of tokens (VIP reward program).

*Disclaimer: This review is not an official consultation or recommendation, advertisement or offer of TokenLab Company and has only informational intention, That is why TokenLab does not hold Any responsibility and does not provide any guarantees related to facts, figures and other Information described in this report.

**If the data in this review differs from the data on the website, the data on the website tokenlab.info should be considered correct.

� TokenLab.info �12